Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa
- 1INSERM U 410; IFR 02, Faculté de Médecine Xavier Bichat, Paris, France.
- 0INSERM U 410; IFR 02, Faculté de Médecine Xavier Bichat, Paris, France.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Leptin administration inhibited the development of precancerous colon lesions in rats, suggesting it does not promote colon cancer. This study indicates leptin is not a potent intestinal growth factor.
Area Of Science
- Gastroenterology
- Endocrinology
- Oncology
Background
- Leptin's role in intestinal growth and carcinogenesis is debated.
- Studies suggest leptin may influence cell proliferation and cancer development.
Purpose Of The Study
- Investigate hyperleptinemia's effects on rat colonic epithelial cell proliferation and aberrant crypts.
- Determine if luminal leptin influences colonic cell proliferation.
Main Methods
- Systemic leptin administration in rats for 7 or 23 days.
- Studied effects of direct colonic leptin infusion.
- Assessed epithelial cell proliferation and aberrant crypt foci formation.
Main Results
- Systemic leptin increased proximal colon cell proliferation but inhibited aberrant crypt foci in chemically induced colon lesions.
- Luminal leptin had no effect on epithelial cell proliferation.
- Systemic leptin reduced plasma insulin levels.
Conclusions
- Leptin inhibits chemically induced precancerous colon lesions, potentially via decreased insulinemia.
- Leptin does not appear to promote colon carcinogenesis.
- Leptin is not a potent growth factor for normal intestinal epithelium.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.